tirzepatide mechanism of action and other GLP1RA as a novel treatment for patients with congenital generalized lipodystrophy Tirzepatide for Weight Loss and

Weight-loss drug Zepbound is being tested as a treatment for long COVID WIRED Remote Long COVID trial to evaluate repurposed drug across US ContagionLive A Q&A with Julia Vogel, a researcher fighting long COVID and searching for relief The San Diego Union-Tribune 5 years later, long Covid is still a medical mystery: What scientists have learned NBC News Can Paxlovid relieve Long COVID symptoms

Common side effects to monitor include fatigue , dizziness , insomnia , and menstrual changes

In China, public and clinical awareness of GLP-1 therapies for overweight and obesity had emerged prior to the approval of Wegovy and Mounjaro and was further strengthened following the drugs mid-2024 approvals for chronic weight management

2013 Dec;38(4):223-9